Iovance Biotherapeutics
Show contact
Links
Previous companies
Frederick G. Vogt
Interim CEO, President & General Counsel
Kerry Elizabeth Wilson Esq.
Executive Counsel
Howard B. Johnson
Chief Business Officer
Jim Ziegler
EVP, Commercial
Kevin Smyth
SVP, Quality
+ 17 more
May, 2022 - present
View in org chart